ArticleOncogene2009
Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.
S Kaulfuss et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleOncogene2009
S Kaulfuss et al.PubMed ↗Publisher ↗
No numbers read from the abstract.